July 21, 2026 02:37 PM GMT Danaher Corporation | North America Resin to Worry? An underwhelming Q2 print and Q3 guide for DHR following another period of growing investor optimism. Life Sciences strength should read positively for more traditional tools players (A, MTD, WAT), but Biotechnology performance presents questions. A disappointing quarter: Heading into the Q2 print, we believe investor sentiment was more constructive on DHR, and while not overly crowded, we sensed a long skew. Broader positive com ...